Grosvenor
ActiveChicago, ILBiotechnology, Healthcare, ManufacturingLast fund filed 2021
10 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| GROSVENOR OPPORTUNISTIC MULTI-CREDIT FUND C | 2021 | Indefinite | $79M | 9 |
| Grosvenor NGLF | September 2019 | Indefinite | $47M | 1 |
| Grosvenor Alternative Investment Completion Portfolio | April 2019 | Indefinite | $564M | 111 |
| Grosvenor Opportunistic Multi-Credit Fund | December 2018 | Indefinite | $200M | 1 |
| Grosvenor Custom HF Strategies | March 2018 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
28 partners are named across this firm’s filings, 10 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Paul Meister | Active | Biotech & pharma, Medical devices | 17 | 4 |
Classified sectors of Grosvenor’s own portfolio companies, based on 10 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Grosvenor Institutional | 29 | ACTIV Surgical, Ambient Biosciences, Apollo Infrastructure Co, Arbor Biotechnologies, Bloc, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Koverse, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Neutron Holdings, Perfect Air Holdco, Quanterix, Scripta Insights, SingleFile Technologies, Swipely, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions, WOLFLAND, ZEFR |
| Grosvenor Alpha | 24 | ACTIV Surgical, Ambient Biosciences, Apollo Infrastructure Co, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Neutron Holdings, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions, WOLFLAND |
| Indefinite |
| $40M |
| 1 |
| Grosvenor Opportunistic Multi-Strategy Fund | 2017 | Indefinite | $104M | 89 |
| Grosvenor Institutional Partners (PF) | December 2016 | Indefinite | $1.1B | 29 |
| Grosvenor Custom Portfolio A | May 2016 | Indefinite | $187M | 68 |
| GROSVENOR ALTERNATIVE INVESTMENT STRATEGIES(TI)LP | March 2016 | Indefinite | $29M | 80 |
| Grosvenor Institutional Partners | 2016 | Indefinite | $617M | 77 |
| GROSVENOR ALTERNATIVE INVESTMENT STRATEGIES(TE)LTD | 2016 | Indefinite | $35M | 86 |
| Grosvenor Direct Opportunities Fund | September 2014 | Indefinite | $106M | 14 |
| Grosvenor FOB Fund | August 2014 | Indefinite | $108M | 2 |
| Grosvenor Opportunistic Credit Fund III (TI) | October 2013 | Indefinite | $69M | 54 |
| Grosvenor Portfolio Completion Strategies Fund FBO MCG Clients, L.P.-Opportunistic Portfolio Series | July 2013 | Indefinite | $272M | 25 |
| Grosvenor Emerging Manager Fund (CI) | April 2013 | Indefinite | $273M | 15 |
| Grosvenor Opportunistic Credit Fund III | February 2013 | Indefinite | $1.3B | 76 |
| Grosvenor Tactical Trading Fund | 2013 | Indefinite | $206M | 1 |
| Grosvenor Alpha Fund | 2013 | Indefinite | $246M | 1 |
| Grosvenor Redwood Fund | October 2012 | Indefinite | $100M | 1 |
| Grosvenor Portfolio Completion Strategies Fund FBO MCG Clients | September 2012 | Indefinite | $152M | 20 |
| Grosvenor Alternative Investments | August 2012 | Indefinite | $315M | 2 |
| Grosvenor Macro Strategies Fund | July 2012 | Indefinite | $72M | 6 |
| Grosvenor Commodity Strategies Fund | July 2012 | Indefinite | $622M | 37 |
| Grosvenor Macro Strategies Fund | July 2012 | Indefinite | $1B | 38 |
| Grosvenor Emerging Manager Fund (US) | May 2012 | Indefinite | $225M | 90 |
| Grosvenor Multi-Strategy Principal Fund | July 2011 | Indefinite | $650M | 2 |
| Grosvenor Enhanced Long/Short Equity Fund (TI) | April 2011 | Indefinite | $159M | 26 |
| Grosvenor See Blue Fund | 2011 | Indefinite | $170M | 1 |
| Grosvenor Enhanced Long/Short Equity Fund | November 2010 | Indefinite | $321M | 8 |
| Grosvenor Wilmore Fund | October 2010 | Indefinite | $453M | 3 |
| Grosvenor Enhanced Long/Short Equity Fund | September 2010 | Indefinite | $339M | 31 |
| Grosvenor Multi-Strategy Leveraged Feeder Fund I | September 2008 | Indefinite | $236M | 85 |
| GROSVENOR ALPHA TRANSPORT FUND (FI) | July 2008 | Indefinite | $200M | 1 |
| GROSVENOR CREDIT STRATEGIES FUND | March 2008 | Indefinite | $64M | 2 |
| GROSVENOR CREDIT OPPORTUNITY FUND SPC | March 2008 | Indefinite | $105M | 3 |
| Grosvenor Monarch Fund | July 2007 | Indefinite | $1.3B | 2 |
| Grosvenor Global Long /Short Equity Fund L P | 2007 | Indefinite | $151M | 3 |
| Grosvenor Global Long/Short Equity Master Fund | July 2006 | Indefinite | $458M | 9 |
| GROSVENOR FARIA FUND | December 2004 | Indefinite | $769M | 6 |
| GROSVENOR AJI FUND | June 2004 | Indefinite | $275M | 1 |
| Grosvenor Institutional U S Hedged Equity Specialists Fund L P | March 2004 | Indefinite | $860M | 25 |
| GROSVENOR LONG/SHORT EQUITY FUND | November 2003 | Indefinite | $249M | 1 |
| GROSVENOR INSTITUTIONAL PARTNERS | 2000 | Indefinite | $12B | 650 |
| GROSVENOR GLOBAL HEDGED EQUITY FUND | 1996 | Indefinite | $176M | 63 |
| GROSVENOR MULTI STRATEGY FUND L P | May 1971 | Indefinite | $1.3B | 582 |
| Eric Levin | Slowing | Digital health | 2 | 1 |
| Joseph LevinNot on the current fund | Slowing | None listed | 2 | 1 |
| Bradley MeyersNot on the current fund | Quiet | None listed | 1 | 0 |
| Brian WolfNot on the current fund | Quiet | None listed | 1 | 0 |
| Burke Montgomery | Quiet | None listed | 0 | 0 |
| Cara FixlerNot on the current fund | Quiet | None listed | 0 | 0 |
| Cassandra PowellNot on the current fund | Quiet | None listed | 0 | 0 |
| Dasha DwinNot on the current fund | Quiet | None listed | 0 | 0 |
| David RichterNot on the current fund | Quiet | None listed | 1 | 0 |
| David SmallNot on the current fund | Quiet | None listed | 1 | 0 |
| Eric FeltonNot on the current fund | Quiet | None listed | 0 | 0 |
| Francis Idehen | Quiet | None listed | 0 | 0 |
| Frederick Pollock | Quiet | None listed | 0 | 0 |
| Ivaldo BassoNot on the current fund | Quiet | None listed | 0 | 0 |
| Jason SneahNot on the current fund | Quiet | None listed | 0 | 0 |
| Jonathan Levin | Quiet | Data & analytics | 1 | 0 |
| Joseph GutmanNot on the current fund | Quiet | None listed | 0 | 0 |
| Joseph NeslerNot on the current fund | Quiet | None listed | 0 | 0 |
| Kevin BuchheitNot on the current fund | Quiet | None listed | 0 | 0 |
| Lilly FarahnakianNot on the current fund | Quiet | None listed | 0 | 0 |
| Michael Sacks | Quiet | Media & creator tools | 1 | 0 |
| Pamela Bentley | Quiet | None listed | 0 | 0 |
| Sandra BuchananNot on the current fund | Quiet | None listed | 0 | 0 |
| Sandra Hurse | Quiet | None listed | 0 | 0 |
| Sean FlynnNot on the current fund | Quiet | Enterprise software, Legal & compliance tech, Sales & marketing tech | 5 | 0 |
| Stacie Selinger | Quiet | None listed | 0 | 0 |
| Tammy JennissenNot on the current fund | Quiet | None listed | 0 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Grosvenor’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Grosvenor Faria | 24 | ACTIV Surgical, Ambient Biosciences, Apollo Infrastructure Co, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Neutron Holdings, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions, WOLFLAND |
| Grosvenor Monarch | 24 | ACTIV Surgical, Ambient Biosciences, Apollo Infrastructure Co, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Neutron Holdings, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions, WOLFLAND |
| MCG Altscape | 22 | ACTIV Surgical, Ambient Biosciences, Arbor Biotechnologies, BlueWhale Bio, C M M S, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions |
| Absolute Return | 21 | ACTIV Surgical, Ambient Biosciences, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions |
| Balcera Fund Ltd | 21 | ACTIV Surgical, Ambient Biosciences, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions |
| Buckeye Fund Ltd | 21 | ACTIV Surgical, Ambient Biosciences, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions |
| Cascade Fund Ltd | 21 | ACTIV Surgical, Ambient Biosciences, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions |
| Charles2 Fund Ltd | 21 | ACTIV Surgical, Ambient Biosciences, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions |
| Clear Box Investments Ltd | 21 | ACTIV Surgical, Ambient Biosciences, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions |
| Corktown Fund Ltd | 21 | ACTIV Surgical, Ambient Biosciences, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions |
| Diversified Absolute Return | 21 | ACTIV Surgical, Ambient Biosciences, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions |
| GCM Fat Hunter | 21 | ACTIV Surgical, Ambient Biosciences, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions |
| GCM Galaxy SPC | 21 | ACTIV Surgical, Ambient Biosciences, Arbor Biotechnologies, BlueWhale Bio, Chainalysis, Everest Biolabs, Flywheel Exchange, INVENTIV HEALTH, Kumanu, LevitasBio, LumaCyte, Luminary Media, Magnolia Medical Technologies, Mercy BioAnalytics, Perfect Air Holdco, Quanterix, Scripta Insights, Telesis Bio, vTv Therapeutics, Warner Music Group, Way Biosolutions |
A shared board seat: a company where filings name a Grosvenor partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.